Celeste Bello, MD, hematologist/oncologist, Moffitt Cancer Center, discusses investigational biomarkers in follicular lymphoma.
Celeste Bello, MD
Advertisement
Articles by Celeste Bello, MD
Advertisement
Latest Updated Articles
Dr. Bello on Biomarkers in Follicular LymphomaAugust 30th 2018
Advertisement
Advertisement
Trending on OncLive
1
FDA Accepts NDA for Daraxonrasib in Previously Treated Metastatic Pancreatic Cancer
2
Teclistamab Plus Talquetamab Yields Significant Survival Benefits in Earlier-Line R/R Myeloma
3
European Commission Approves Camizestrant Plus CDK4/6 Inhibition for Emergent ESR1-Mutated Advanced Breast Cancer
4
Dr Pant on the Potential Significance of Daraxonrasib for PDAC Management
5